SciELO - Scientific Electronic Library Online

vol.15 issue3Capitalism and anguishDrugs, biopolitics and subjectivity: interface between psychoanalysis and genealogy author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista Subjetividades

Print version ISSN 2359-0769On-line version ISSN 2359-0777


GADELHA, Sylvio. Biopolitics, biotechnology and biomedicine. Rev. Subj. [online]. 2015, vol.15, n.3, pp. 407-416. ISSN 2359-0769.

The article is a free trial in which it seeks to address some aspects or faces of the relationship between biopolitics, biotechnology and biomedicine, viewing them in reference to a wider background picture, namely of a highly bio-political nihilism, characteristic of the new capitalism that has taken shape since about the second half of the 1970s, which is neoliberal, globalized, transnational, financial and connectionist. The article is divided into two parts. In the first one, without extensive claims, on one hand, some factors considered relevant to the establishment of new assemblages between biopolitics and biotechnologies are examined, and on the other, continuities and ruptures to be observed in the exercise of biopolitics, the transition between modern societies governed by a disciplinary logic, and contemporary societies, governed by a control logic. Nikolas Rose's studies and researches are, therefore, privileged as important intercessors for the considerations made. In the second part, the article seeks to describe, characterize, distinguish and comment, even briefly, three different versions of "immoralist's projects", i.e. projects involving a link between biopolitics, biotechnology and biomedicine, in a period extending from the early twentieth century to our present, in order to bypass, contour, avoid or overcome death, that is, human finitude.

Keywords : biopolitics; biotechnology; biomedicine; imperialism; uniqueness.

        · abstract in Portuguese | Spanish | French     · text in Portuguese     · Portuguese ( pdf )


Creative Commons License